Related Experiment Video
Updated: Dec 20, 2025
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.4K
Progress and challenges in gastroesophageal cancer
Olbia Serra1, Elizabeth C Smyth2, Florian Lordick3
1Catalan Institute of Oncology, Medical Oncology Service, Hospital Durany Reynals, Hospitalet de Llobregat, Barcelona, Spain.
Current Problems in Cancer
|May 27, 2020
Summary
Gastroesophageal adenocarcinoma (GEA) remains challenging, with limited targeted therapies. Advances in understanding GEA biology, biomarkers, and immune checkpoint blockade offer new hope for improved patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Gastroesophageal adenocarcinoma (GEA) presents a significant clinical challenge, with poor survival rates in advanced stages.
- Development of targeted therapies for GEA has been hindered by molecular heterogeneity and biomarker expression variability.
- Recent molecular insights have identified potential prognostic/predictive biomarkers and novel therapeutic targets.
Purpose of the Study:
- To review current understanding of GEA biology and its implications for treatment.
- To examine prognostic and predictive biomarkers relevant to GEA.
- To discuss recent clinical trial outcomes, including targeted therapies and immune checkpoint blockade.
Main Methods:
- Literature review of GEA biology, biomarker studies, and clinical trials.
- Analysis of heterogeneity in GEA, including liquid biopsy applications.
- Examination of immune checkpoint blockade strategies (anti-PD-1, anti-CTLA4, anti-PD-L1) in GEA.
Main Results:
- Biomarker heterogeneity poses challenges for targeted drug development in GEA.
- Liquid biopsy shows promise for complementing tissue diagnosis and guiding treatment decisions.
- Immune checkpoint blockade trials reveal complex interactions between GEA tumors and the immune microenvironment.
Conclusions:
- Understanding GEA heterogeneity is crucial for developing effective targeted therapies.
- Liquid biopsy may enhance personalized treatment strategies in GEA.
- Immune checkpoint blockade represents a promising future therapeutic avenue for GEA, pending further research.
Related Concept Videos
01:21Barrett Esophagus-II: Clinical Manifestations and Management
631
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
631
01:21Barrett Esophagus-I: Introduction
463
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
463
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
587
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
587
01:26Esophageal Strictures-II: Clinical Features and Management
319
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
319
01:28Esophageal Varices-II: Clinical Features and Management
290
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
290
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K